AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliclagood M 60 Tablet ER

Prescription Icon
Prescription Required

Marketer

Workcell Solutions Private Limited

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Gliclagood M 60 Tablet ER

DiabetaComb 60 ER tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. DiabetaComb 60 ER should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carry a fast-acting sugar source to counter hypoglycemia. Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. DiabetaComb 60 ER is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your doctor of any history of heart disease before starting this medication. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood sugar checks are necessary, and your physician may order blood tests to monitor blood cell counts and liver function.

Uses of Gliclagood M 60 Tablet ER

Adult-onset diabetes

Major Benefits of Gliclagood M 60 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliclagood M 60 Tablet ER should be administered with a meal.

Common Side effects of Gliclagood M 60 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gliclagood M 60 Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliclagood M 60 Tablet ER should be administered with a meal.

How Gliclagood M 60 Tablet ER works:

Extended-release Gliclagood M 60 tablets contain a dual-action formulation of gliclazide and metformin, both used in diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliclagood M 60 Tablet ER and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Gliclagood M 60 tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Gliclagood M 60 Tablet may pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk with possible adverse effects on the baby.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliclagood M 60 Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliclagood M 60 Tablet ER cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A low starting dose is typically recommended for individuals with mild to moderate liver disease; however, its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Gliclagood M 60 Tablet ER :

Should you forget a dose of Gliclagood M 60 Tablet ER, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gliclagood M 60 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliclagood M 60 Tablet ER

Gliclagood M 60 Tablet ER combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It helps control blood sugar when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Gliclagood M 60 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclagood M 60 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclagood M 60 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). While rare, this side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliclagood M 60 Tablet ER and seek immediate medical attention.
Prolonged Gliclagood M 60 Tablet ER use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Gliclagood M 60 Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Gliclagood M 60 Tablet ER is unsafe. It can worsen low blood sugar and raise the risk of lactic acidosis.
Gliclagood M 60 Tablet ER combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 diabetes.
Gliclagood M 60 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Gliclagood M 60 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Gliclagood M 60 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). While rare, this risk is heightened in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliclagood M 60 Tablet ER and seek immediate medical attention.
Prolonged use of Gliclagood M 60 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Gliclagood M 60 Tablet ER is contraindicated in patients allergic to its components or excipients, and in those with moderate-to-severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining alcohol with Gliclagood M 60 Tablet ER is unsafe. This combination may dangerously lower blood sugar and raise the risk of lactic acidosis.
Gliclagood M 60 Tablet ER
130
MRP 150
13% off